The CAR-T Space is Heating Up, Who Could Be the Next Target?

CAR-T treatment is short for chimeric antigen receptor T-cell therapy. CAR-T treatment removes a person's cells from the body, reengineers them, and then puts...

Trade Shows are the New Battle Ground for Indoor Positioning Analytics

Indoor Positioning Analytics (IPA) and Indoor Positioning Systems (IPS) Technology make use of sensors that pick up Wi-Fi, Bluetooth and cellular signals to precisely...

Emerald Health Therapeutics Positioning Itself for Revenue Growth & Differentiation

On October 17, recreational cannabis will become federally legalized in Canada. One of the largest, yet under-the-radar Canadian-based cannabis companies is Emerald Health Therapeutics Inc....

A New Standout in Middle-Market Coal: American Resources

Why Coal? Why now? We’re all fans of green energy and we’re big proponents for the industry. But coal is still the preeminent natural resource...

Inpixon Set to Disrupt B2B Cybersecurity Market

Cybersecurity is one of the largest threats to privacy and integrity of company information in the modern era. In 2013, Cisco forecasted that “smart”...

In the Cannabis World Seeing is Believing

It’s difficult for the human mind to conceptualize large numbers. For example, it’s easier to understand the concept of $10 than $1 billion. For...

The End of Breast Cancer Could Be Through Prevention Rather Than Cure

Dr. Steven Quay, CEO of Atossa Genetics and a board-certified Anatomic Pathologist, discusses Atossa’s promising candidate in the fight against breast cancer. Queen Atossa of...

Catalysts Are Moving Cannabis Producer Emerald Health Therapeutics

By: Dr. George S. Mack, Principal Analyst at BioDecade In the last week of July there were two important developments at Vancouver, British Columbia (BC)...

A Fast-Growing Coal Company with a Head of Steam

Coal may be a dirty word in social circles, but the fact remains that coal is still the preeminent natural resource on the planet...

Inpixon Spinoff of Sysorex Could be Significant Growth Catalyst

In a few weeks, Inpixon is expected to spin off its VAR business into a separate public company which will be called Sysorex. Inpixon...

Canada’s Cannabis Gem – Emerald Health Therapeutics

By: Dr. George S. Mack, Principal Analyst at BioDecade All the people at Victoria, British Columbia-based Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) awakened on June...

Investors Have $31 Million Reasons to Believe in Inpixon Turnaround

Inpixon (INPX) has been propelled by over $31 million in capital raised from investors in the first quarter of 2018.  It’s not often that...

Enter your email below to receive free content